Outlook Therapeutics, Inc.OTLKNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-106.10%
↓ 407% below average
Average (39q)
34.55%
Historical baseline
Range
High:902.66%
Low:-106.10%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -106.10% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | -100.00% |
| Q3 2019 | 902.66% |
| Q2 2019 | -8.94% |
| Q1 2019 | -39.97% |
| Q4 2018 | 38.36% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -73.40% |
| Q3 2017 | 857.31% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -38.75% |
| Q3 2016 | 0.00% |
| Q2 2016 | -50.26% |
| Q1 2016 | 0.00% |
| Q4 2015 | 101.03% |